[Osteoporosis therapy. Bisphosphonates compared].
D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use*; D015519:Bone Density; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D012968:Etidronic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy*; D010919:Placebos; D000068296:Risedronic Acid; D013997:Time Factors
D004164:Diphosphonates; D010919:Placebos; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate